1. A patient with ALK‐positive lung adenocarcinoma who survived alectinib‐refractory postoperative recurrence for 4 years by switching to ceritinib. Issue 15 (23rd June 2021) Authors: Matsumura, Yuki; Inomata, Sho; Yamaguchi, Hikaru; Mine, Hayato; Takagi, Hironori; Watanabe, Masayuki; Ozaki, Yuki; Yamaura, Takumi; Fukuhara, Mitsuro; Muto, Satoshi; Okabe, Naoyuki; Hasegawa, Takeo; Shio, Yutaka; Suzuki, Hiroyuki Journal: Thoracic cancer Issue: Volume 12:Issue 15(2021) Page Start: 2225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004). (March 2021) Authors: Takagi, Hironori; Zhao, Songji; Muto, Satoshi; Yokouchi, Hiroshi; Nishihara, Hiroshi; Harada, Toshiyuki; Yamaguchi, Hikaru; Mine, Hayato; Watanabe, Masayuki; Ozaki, Yuki; Inoue, Takuya; Yamaura, Takumi; Fukuhara, Mitsuro; Okabe, Naoyuki; Matsumura, Yuki; Hasegawa, Takeo; Osugi, Jun; Hoshino, Mika... Journal: Lung cancer Issue: Volume 153(2021) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Inhibitory effect of tacrolimus on progression of joint damage in patients with rheumatoid arthritis. (20th November 2013) Authors: Motomura, Hiraku; Matsushita, Isao; Seki, Eiko; Mine, Hayato; Kimura, Tomoatsu Journal: International journal of rheumatic diseases Issue: Volume 17:Number 7(2014) Page Start: 747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report. Issue 19 (5th September 2022) Authors: Watanabe, Masayuki; Matsumura, Yuki; Yamaguchi, Hikaru; Mine, Hayato; Takagi, Hironori; Ozaki, Yuki; Fukuhara, Mitsuro; Muto, Satoshi; Okabe, Naoyuki; Shio, Yutaka; Suzuki, Hiroyuki Journal: Thoracic cancer Issue: Volume 13:Issue 19(2022) Page Start: 2817 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pulmonary large cell carcinoma, highly positive for PD‐L1, shows marked response to pembrolizumab: A case report. Issue 7 (19th February 2021) Authors: Okabe, Naoyuki; Mine, Hayato; Takagi, Hironori; Watanabe, Masayuki; Muto, Satoshi; Matsumura, Yuki; Shio, Yutaka; Suzuki, Hiroyuki Journal: Thoracic cancer Issue: Volume 12:Issue 7(2021) Page Start: 1141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗